官方服务：
资源简介：
Univariate predictors of non-SVR.
应用场景：
创建时间：
2019-10-03
相关数据集
Response rates after 3 years’ follow-up according to HBsAg level at Weeks 12 and 24 of treatment in HBeAg-positive patients.
mITT patients with available data.
Figshare2020-04-10 更新50
Rate of detectable and undetectable HBV DNA, among the treated and untreated groups, and comparing different therapeutic combination.
Rate of detectable and undetectable HBV DNA, among the treated and untreated groups, and comparing different therapeutic combination.
Figshare2018-01-10 更新20
Intrahepatic transcriptomics reveals gene signatures in chronic hepatitis B patients responded to interferon therapy
Chronic hepatitis B virus (HBV) infection remains a substantial public health burden worldwide. Alpha-interferon (IFNα) is one of the two currently approved therapies for chronic hepatitis B (CHB), to
NIAID Data Ecosystem20
Table_2_Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patients.doc
ObjectiveTo explore dynamic changes of cytokines and virological markers associated with hepatitis B surface antigen (HBsAg) loss during peginterferon alpha-2a (PEG-IFN α-2a) treatment in hepatitis B
NIAID Data Ecosystem30
Genetic complexity at pre-treatment and 1 week after PEG-IFNα2b plus ribavirin combination therapy in immediate virologic responders and non-responders.
Wilcoxon rank sum test. * p = 0.037. ** p = 0.12.
NIAID Data Ecosystem20
